ITP
BLFS icon

Iron Triangle Partners’s BioLife Solutions BLFS Stock Holding History

Iron Triangle Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-150,000
Closed -$4.34M – 27
2020
Q3 		$4.34M Buy
+150,000
New +$3.24M 0.97% 24

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Iron Triangle Partners's BLFS Position: Q4 2020 in Review

Iron Triangle Partners sold out of BioLife Solutions (BLFS) in Q4 2020, closing a stake of 150,000 shares — an estimated $4.34M sold.

Iron Triangle Partners first reported a position in BLFS in Q3 2020 and held it in 1 quarter. The position peaked at $4.34M in Q3 2020. 128 funds tracked by Wall St. Rank hold BLFS as of Q4 2020.

  • Iron Triangle Partners reported no remaining BioLife Solutions position as of Q4 2020 after selling out during the quarter.
  • Iron Triangle Partners sold 150,000 BioLife Solutions shares in Q4 2020, an estimated $4.34M.
  • Iron Triangle Partners first reported a position in BioLife Solutions in Q3 2020 and held it in 1 quarter.
  • Iron Triangle Partners's BioLife Solutions position peaked at $4.34M in Q3 2020.
  • 128 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2020.

Based on Iron Triangle Partners's 13F filing for Q4 2020, filed 16 Feb 2021.